Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis
about
Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosusOlfactomedin 2, a novel regulator for transforming growth factor-β-induced smooth muscle differentiation of human embryonic stem cell-derived mesenchymal cellsExpression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation.Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbitsPotential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in ratsSmooth muscle myosin heavy chain isoforms and their role in muscle physiologyMyosin heavy chain gene expression in normal and hyperplastic human prostate tissueG-protein-coupled-receptor activation of the smooth muscle calponin geneThe smooth muscle alpha-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells.Nuclear proteins bind a cis-acting element in the smooth muscle alpha-actin promoter.Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements.Interaction of CArG elements and a GC-rich repressor element in transcriptional regulation of the smooth muscle myosin heavy chain gene in vascular smooth muscle cells.Alterations in expression of myosin and myosin light chain kinases in response to vascular injury.Targeted expression of SV40 large T-antigen to visceral smooth muscle induces proliferation of contractile smooth muscle cells and results in megacolonMolecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.Comparison of vascular smooth muscle cells in canine great vessels.Stabilization of atherosclerotic plaques: new mechanisms and clinical targets.Regulation of smooth muscle phenotype.Syndecan-1 regulates vascular smooth muscle cell phenotype.Smad2 and PEA3 cooperatively regulate transcription of response gene to complement 32 in TGF-β-induced smooth muscle cell differentiation of neural crest cells.Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitroEmbryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of CajalCell division cycle 7 is a novel regulator of transforming growth factor-β-induced smooth muscle cell differentiation.Transforming growth factor-β and smooth muscle differentiationMolecular and Cellular Characteristics of the Colonic Pseudo-obstruction in Patients With Intractable Constipation.Identification of promoter elements involved in cell-specific regulation of rat smooth muscle myosin heavy chain gene transcription.Nonmuscle myosin heavy chain-B expression in balloon-dilated and stented arteries: a study in the atherosclerotic Yucatan micropigAblation of smooth muscle myosin heavy chain SM2 increases smooth muscle contraction and results in postnatal death in micePerivascular cells in blood vessel regeneration.Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans.Macrophage Notch Ligand Delta-Like 4 Promotes Vein Graft Lesion Development: Implications for the Treatment of Vein Graft Failure.Cell division cycle 7 mediates transforming growth factor-β-induced smooth muscle maturation through activation of myocardin gene transcription.H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells.Fibroblast growth factor 2 control of vascular tone.Arp5 is a key regulator of myocardin in smooth muscle cellsWhy are the intramyocardial portions of the coronary arteries spared from arteriosclerosis? Clinical implications.Review of molecular and mechanical interactions in the aortic valve and aorta: implications for the shared pathogenesis of aortic valve disease and aortopathy.Thin-capped atheromata with reduced collagen content in pigs develop in coronary arterial regions exposed to persistently low endothelial shear stress.Krüppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype.Tissue-Engineered Grafts Matured in the Right Ventricular Outflow Tract.
P2860
Q24302408-0ED0F2E7-716A-4DB9-AD79-C63C73FF71C8Q24305366-54A9E2B7-40D2-4D34-BB5D-B87AEB6CC3EEQ24603483-EE0F24B1-CE3C-42CB-903B-24DA266D6FE2Q24669902-EDE5B2BE-7462-464B-B462-5DF8E62FD85CQ27313498-381BA05E-6784-4A86-967C-A383513FA9A5Q28139248-E4F7A478-8665-4780-B802-6B8916AFB3C0Q28141527-0E929D59-CBB8-4CF8-8EBA-470168B23CB8Q28343628-ACC17EDB-70CA-4119-B29C-6A7FED467D20Q30464808-C771B995-DCEF-4EAD-A0CB-B40A869351C7Q30465020-BA43848A-F286-4744-9D88-48C2F8B51815Q30470081-123C72FC-5C03-477A-9734-81B5AC5CE3FEQ30471257-A775358C-C198-4A81-8688-A6A2DAA44A78Q33668418-7869B5EF-2653-460A-9A4A-36FCFB17FF4AQ33668471-0EF04EBA-9B34-47F7-9C6B-37EE6318405EQ34146262-982B2DE7-A057-478B-8980-365431A24AEAQ34636879-90B861EA-BE15-41D0-85E7-DEE0455AE552Q34986368-21C42ACF-F2E5-4B9C-B339-B34735CA860EQ35095426-D648345E-6A21-45E8-9B2D-3EF6C9524825Q35108169-DC2321D0-83E5-47E6-B1DF-3D934C9D87E1Q35159428-5E0DBA00-1B50-4604-8A31-83A734F80A85Q35746931-10BC57B7-8F17-4D02-973E-484B703C7C19Q35754561-8EF0261A-9C17-4F8C-A9DC-7EC95F459B78Q35838998-3B214EFB-16A0-4FD6-B3F0-2359F4564EAEQ35852389-6B4A201E-1EB4-4837-8DC1-AB0652C75B0DQ36211758-4138DD68-62F8-4EE0-BE79-78CD713253FCQ36802943-30A008AB-27AB-4B82-B039-16724FCBC099Q36813345-A2EBDAF2-EE74-405A-86D6-2F8E28114375Q36984891-02D7F79B-3AE2-46E7-A13C-EF7446277DBDQ37095242-7303B9A0-58DB-4752-8735-4EF3769ADE79Q37145550-95820783-19F0-4848-964C-1F3EB78DF46CQ37213317-BF36DF4B-0FC4-4465-AB16-150AAA8FA5E1Q37348858-FF19DF13-5570-4964-9C12-1FC5EE9C088FQ37352630-C7473D1F-600C-4F3E-A4CE-1EF3F3714B74Q37362801-99764AD5-CBE4-48C7-B9BC-F3E976C30EC7Q37614849-0D729EED-11C0-4BC5-80C9-B8E32BB54297Q38000154-586699F6-633F-46F8-B576-7C0180C202C4Q38269616-6CF8A668-36B8-4096-8DBE-D0BA7FBD4EEEQ38274882-E06CA474-7080-4B8B-961B-4B89EB5C469FQ38358459-13664C0F-46FF-4C04-812B-9D475A2F3CF7Q38602335-E00DA355-0B06-42E7-9435-BAF785C2E80D
P2860
Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Human smooth muscle myosin hea ...... evelopment and atherosclerosis
@ast
Human smooth muscle myosin hea ...... evelopment and atherosclerosis
@en
Human smooth muscle myosin hea ...... evelopment and atherosclerosis
@nl
type
label
Human smooth muscle myosin hea ...... evelopment and atherosclerosis
@ast
Human smooth muscle myosin hea ...... evelopment and atherosclerosis
@en
Human smooth muscle myosin hea ...... evelopment and atherosclerosis
@nl
prefLabel
Human smooth muscle myosin hea ...... evelopment and atherosclerosis
@ast
Human smooth muscle myosin hea ...... evelopment and atherosclerosis
@en
Human smooth muscle myosin hea ...... evelopment and atherosclerosis
@nl
P2093
P3181
P356
P1433
P1476
Human smooth muscle myosin hea ...... evelopment and atherosclerosis
@en
P2093
H Yamaguchi
K Nakahara
S Takewaki
P304
P3181
P356
10.1161/01.RES.73.6.1000
P407
P577
1993-12-01T00:00:00Z